A Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics (PK) of a Single Intravenous (IV) TAK-954

Clinical trial NCT03296787 · COMPLETED

Trial details

NCT number: NCT03296787
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Impairment Healthy Volunteers

Start date: 2017-11-21
Primary completion: 2019-08-09
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.